Dean Y Li insider trades: Merck (MRK) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Dean reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | MRK | ↓ Sell | 10,235 | $117.52 | $1.2M | Direct | Feb 10, 2026 (0d) |
| Feb 4, 2026 | MRK | ↓ Sell | 15,087 | $118.77 | $1.8M | Direct | Feb 6, 2026 (2d) |
| Feb 9, 2024 | MRK | ↓ Sell | 14,702 | $125.50 | $1.8M | Direct | Feb 12, 2024 (3d) |
| Jan 9, 2024 | RXRX | ↓ Sell | 29,000 | $13.66 | $396K | By Dean Y. Li 2021 Family Trust | Jan 11, 2024 (2d) |
| Dec 7, 2021 | RXRX | ↓ Sell | 15,900 | $20.48 | $326K | By Dean Y. Li 2021 GRAT | Dec 9, 2021 (2d) |
| Nov 19, 2021 | RXRX | ↓ Sell | 19,100 | $20.16 | $385K | Direct | Nov 19, 2021 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MRK insiders
Open-market trades in the last 12 months
About Dean Y Li's insider trades
Dean Y Li is Executive VP & President, MRL at Merck (MRK). Since Nov 19, 2021, Dean has reported no open-market purchases and 6 sales worth $5.9M on SEC Form 4. In the last 12 months: 2 sales ($3.0M).
Their filings also include grants and awards (40 filings), option exercises (7 filings), shares withheld for taxes (5 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.